4-amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one lamivudine 134678-17-4 Epivir Zeffix Epivir-HBV (-)-2'-Deoxy-3'-thiacytidine GR-109714X VIROLAM (-)-BCH-189 GR109714X 3'-Thia-2',3'-dideoxycytidine Lamivudine teva 4-AMINO-1-[(2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]-2(1H)-PYRIMIDINONE beta-L-2',3'-Dideoxy-3'-thiacytidine beta-L-3'-Thia-2',3'-dideoxycytidine 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one BCH 189, (-)- Lamivudina Lamivudinum GR 109714X (-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine BCH189 4-AMINO-1-[(2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]-1,2-DIHYDROPYRIMIDIN-2-ONE CHEBI:63577 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one 2T8Q726O95 NSC-760061 (-)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine 4-Amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone DTXSID7023194 TRIUMEQ COMPONENT LAMIVUDINE LAMIVUDINE TEVA PHARMA B.V. TRIZIVIR COMPONENT LAMIVUDINE DELSTRIGO COMPONENT LAMIVUDINE 2(1H)-Pyrimidinone, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-cis)- 2(1H)-Pyrimidinone, 4-amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)- LAMIVUDINE/ZIDOVUDINE TEVA COMPONENT LAMIVUDINE Epivir HBV 2(1H)-Pyrimidinone, 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]- lamivudine oral 3TC Lamivudine 2',3' Dideoxy 3' thiacytidine 4-amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-1,2-dihydropyrimidin-2-one 4-amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2-one Lamivudine, 3TC RefChem:798426 J05AF05 DTXCID001508532 603-844-3 Heptovir 136891-12-8 3TC BCH-189 Heptodin Lamivir CIS-LAMIVUDINE 4-Amino-1-(cis-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one (-)NGPB-21 MFCD00869739 Hepitec Zefix Heptivir BCH 189 Lamivudine [USAN:BAN:INN] (-)-(2'R,5'S)-1-[2'-Hydroxymethyl-5'-(1,3-oxathiolanyl)]cytosine 2(1H)-Pyrimidinone,4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, rel- Epivir(TM) HHA & Lamivudine Lamivudine & GNA SMR000466319 Epivir (TN) (-)-BCH 189 DTHC rac-cis-Lamivudine ((2RS,5SR)-Lamivudine) CHEMBL141 HSDB 7155 DRG-0126 GG-714 3TC and NV-01 (-)-SddC Lamivudeine Lamivudine (JAN/USP/INN) 3TC & GNA 3TC & SST HHA & 3TC (+/-)-SddC CCRIS 9274 Lamivudine RS NSC620753 Lamivudine CRS Epivir; UNII-2T8Q726O95 BCH-790 Lamivudine [USAN:USP:INN:BAN] NCGC00159341-04 Lamivudine (Standard) Lamivudine (EPIVIR) CPD000466319 LAMIVUDINE [MI] (+/-)-3TC (+/-)-BCH-189 LAMIVUDINE [INN] LAMIVUDINE [JAN] LAMIVUDINE [HSDB] LAMIVUDINE [USAN] LAMIVUDINE [VANDF] Epitope ID:613392 LAMIVUDINE [MART.] 2(1H)-Pyrimidinone, 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, rel- LAMIVUDINE [USP-RS] LAMIVUDINE [WHO-DD] LAMIVUDINE [WHO-IP] Lamivudine, cis-(+/-)- US4RZW252L MLS000759424 MLS001424097 MLS006011910 BIDD:GT0033 LAMIVUDINE [EMA EPAR] SCHEMBL109675 Lamivudine - Bio-X trade mark orb1310390 orb3141279 LAMIVUDINE [EP IMPURITY] LAMIVUDINE [ORANGE BOOK] GTPL12673 HY-B0250R LAMIVUDINE [EP MONOGRAPH] KIVEXA COMPONENT LAMIVUDINE GLXC-05058 HMS2051D21 HMS3259F08 HMS3713C16 LAMIVUDINE [USP MONOGRAPH] EPZICOM COMPONENT LAMIVUDINE LAMIVUDINUM [WHO-IP LATIN] TEMIXYS COMPONENT LAMIVUDINE ALBB-038661 COMBIVIR COMPONENT LAMIVUDINE HY-B0250 MSK10170 Lamivudine for system suitability RS BBL033871 BDBM50366817 EBC-03887 s1706 SBB066293 STK801940 lamivudine & TNF-alpha & IFN-gamma AKOS005622556 AKOS015854841 Lamivudine, >=98% (HPLC), powder (-)-BCH189 AC-1416 CCG-100984 DB00709 KS-1073 NC00234 NC00705 NL06295 NSC 760061 Lamivudine for system suitability 1 CRS NCGC00159341-05 NCGC00159341-18 NCGC00159341-20 BL164607 EMTRICITABINE IMPURITY C [WHO-IP] L0217 NS00007004 SW197614-3 C07065 D00353 EN300-123034 Lamivudeine 100 |Ig/mL in Acetonitrile:Water Lamivudine 100 microg/mL in Acetonitrile:Water P17147 AB00639995-06 AB00639995-08 AB00639995_09 F227713 Q422631 SR-01000759420 SR-01000759420-5 BRD-K02992638-001-11-8 Z1509637175 Lamivudine Working Standard (Secondary Reference Standard) Lamivudine, British Pharmacopoeia (BP) Reference Standard Lamivudine, European Pharmacopoeia (EP) Reference Standard (2R,5S)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine .beta.-L-(-)-2',3'-dideoxy-3'-thiacytidine & Sho-Saiko-To cis(+/-)-2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane Lamivudine, United States Pharmacopeia (USP) Reference Standard (+/-) (Cis)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (-)-L-2',3'-DIDEOXY-3'-THIACYTIDINE; LAMIVUDINE; EPIVIR Lamivudine, 1.0 mg/mL in methanol, certified reference material Lamivudine, Pharmaceutical Secondary Standard; Certified Reference Material (+/-)-(cis)-4-Amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (+/-) (Cis) 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, cis- 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, cis-(+/-)- 3-[(5S,2R)-2-(hydroxymethyl)(1,3-oxathiolan-5-yl)]-6-amino-3-hydropyrimidin-2- one 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-[1,3]-oxathiolan-5-yl]-(1H)-pyrimidin-2-one 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-Oxathiolan-5-yl]-(1H)-pyrimidin-2-one cis(+/-)-4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone Lamivudine for system suitability 1, European Pharmacopoeia (EP) Reference Standard Lamivudine for system suitability 2, European Pharmacopoeia (EP) Reference Standard rel-4-Amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone 1117764-41-6 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) & Galanthus Nivalis Agglutinin (GNA) 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) & Hippeastrum hybrid agglutinin( HHA) 4-AMINO-1-((2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)PYRIMIDIN-2(1H)-ONE [WHO-IP]
Show all 212 synonyms 
